DiaMedica Therapeutics Inc. Common Stock

$8.05
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.37 (-4.39%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell DMAC and other stocks, options, and ETFs commission-free!

About DMAC

DiaMedica Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It offers DM199 product which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD). The company was founded by Wayne Lautt on January 21, 2000 and is headquartered in Minneapolis, MN. The listed name for DMAC is DiaMedica Therapeutics Inc. Common Stock.

CEO

Rick John Pauls

Employees

Headquarters

Minneapolis, Minnesota

Founded

2000

Market Cap

142.59M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

223.99K

High Today

$8.47

Low Today

$7.95

Open Price

$8.30

Volume

234.38K

52 Week High

$10.88

52 Week Low

$1.87

Collections

DMAC Earnings

-$0.21

-$0.14

-$0.07

-$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 22, After Hours